公司资料
Silence Therapeutics 股价、新闻与催化剂
- 股票代码:
- SLN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United Kingdom
股票表现
9.83 USD (-3.06%)
收盘价
最后更新: 2026年10月6日
301M USD
市值
股价为何变动
截至 2026年10月6日，SLN 下跌 3.06%，收于 $9.83。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Silence Therapeutics is an RNA interference company focused on targeted gene silencing. Its story is built around translating RNAi into precision medicines for cardiovascular and hematologic disease.
所在地与行业分类
Silence Therapeutics is headquartered in the United Kingdom and listed on NASDAQ. It sits in RNA therapeutics and platform biotechnology.
商业模式特征
The company depends on translational validation, clinical progress, and the ability to turn RNAi science into durable therapeutic value. Investors watch data, partnerships, and pipeline execution.
生物医药行业定位
Silence occupies a premium RNAi niche within biotech. The stock is sensitive to whether the platform can keep validating beyond the first wave of programs.
未来催化剂
- Silence Therapeutics’ catalysts are RNAi-platform programs and any clinical update that shows the delivery / target-silencing story still has real momentum. The company remains very platform-dependent.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。